Target
Kallikrein-1
Ligand
BDBM50138670
Substrate
n/a
Meas. Tech.
ChEBML_148015
Ki
2500±n/a nM
Citation
 Wendt, MDGeyer, AMcClellan, WJRockway, TWWeitzberg, MZhao, XMantei, RStewart, KNienaber, VKlinghofer, VGiranda, VL Interaction with the S1 beta-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors. Bioorg Med Chem Lett 14:3063-8 (2004) [PubMed]  Article 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM50138670
Synonyms:
6-Carbamimidoyl-naphthalene-2-carboxylic acid phenylamide | 6-[(Z)-AMINO(IMINO)METHYL]-N-PHENYL-2-NAPHTHAMIDE | 6-carbamimidoyl-N-phenyl-2-naphthamide | CHEMBL104937 | uPa_7
Type:
Small organic molecule
Emp. Form.:
C18H15N3O
Mol. Mass.:
289.3312
SMILES:
NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccccc1
Structure:
Search PDB for entries with ligand similarity: